SCAI Therapeutics is a drug delivery platform that utilizes targeted delivery mechanisms to enhance the efficacy of pharmaceutical compounds. The company addresses the challenge of suboptimal drug absorption and distribution, aiming to improve therapeutic outcomes for patients.
Funding
$34.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many pharmaceutical compounds suffer from suboptimal absorption and distribution within the body, limiting their therapeutic efficacy and potentially causing systemic side effects. Traditional drug delivery methods often fail to precisely target affected tissues, resulting in reduced drug concentrations at the site of action.
Solution
SCAI Therapeutics develops targeted drug delivery systems designed to enhance the bioavailability and precision of pharmaceutical compounds. Their platform utilizes proprietary targeting mechanisms to direct drugs specifically to the intended tissues or cells, maximizing therapeutic impact while minimizing off-target effects. By improving drug absorption and distribution, SCAI Therapeutics aims to increase the effectiveness of existing and novel therapies, potentially reducing dosage requirements and improving patient outcomes. The technology seeks to overcome the limitations of conventional drug delivery, offering a more efficient and controlled approach to drug administration.
Target Audience
SCAI Therapeutics targets pharmaceutical companies seeking to improve the delivery and efficacy of their drug candidates, as well as researchers developing novel therapeutic agents.
Features
- Ligand-targeted nanoparticles for selective drug accumulation in diseased tissues
- pH-sensitive drug release mechanisms for controlled payload delivery within the target environment
- Enhanced permeation and retention (EPR) effect optimization for improved drug penetration into tumors
- Biocompatible and biodegradable carrier materials for safe and sustained drug release